Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR
about
sameAs
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activityPKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling.Double-stranded RNA-dependent protein kinase is involved in 2-methoxyestradiol-mediated cell death of osteosarcoma cells.Stat1 phosphorylation determines Ras oncogenicity by regulating p27 kip1Increased expression of the dsRNA-activated protein kinase PKR in breast cancer promotes sensitivity to doxorubicinInterferons induce tyrosine phosphorylation of the eIF2alpha kinase PKR through activation of Jak1 and Tyk2.Altered PKR Signalling and C / EBPβ Expression is Associated with HLA-B27 Expression in Monocytic Cells.A novel function of eIF2alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathwayControl of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death.Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors.Modulation of the eukaryotic initiation factor 2 alpha-subunit kinase PERK by tyrosine phosphorylation.The catalytic activity of the eukaryotic initiation factor-2alpha kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase.Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis.
P2860
Q24337310-197BBEE6-8539-4382-AE42-58D0B178753CQ27472907-8CDC8EA2-DDAA-45E1-9F39-563299B82457Q28504645-9B408F0E-07D6-4159-9B1F-EC0EA6FC0C3FQ33259077-0EFDE471-F255-4738-92B0-3D9827CD9360Q33378494-77DB113B-423B-402F-820E-AE427A4CB88FQ34430670-AE278AD2-329D-47A1-BA74-7A49BECDB081Q35658377-7FA1C5FF-2323-4935-BCF6-B080D6F6A7A1Q35729762-8EFFC985-A16E-4806-9431-BA19C4575AADQ35949097-A3B8DF1F-1216-46F7-8576-F10F7E970C51Q37277545-D522D0D1-C689-4838-80CD-8829E2100981Q37610446-A20126AF-2645-4973-90B6-DC7C775A3664Q39700439-BF410F06-9D6A-4840-9AE5-B159C8884D32Q40052972-D8B196BA-209E-49E7-AAA6-874CBE6BFFA5Q46907819-3EC6840F-277B-4467-93E9-118A401E2FBEQ53959858-D90A9B4F-696B-4A91-871C-1437610A06B6
P2860
Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@ast
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@en
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@nl
type
label
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@ast
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@en
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@nl
prefLabel
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@ast
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@en
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@nl
P2093
P2860
P356
P1476
Enhanced antiviral and antipro ...... ct with the protein kinase PKR
@en
P2093
P2860
P304
13727-13737
P356
10.1074/JBC.M011240200
P407
P50
P577
2001-01-25T00:00:00Z